About this trial
Noncommunicable diseases (NCDs) such as type 2 diabetes (T2D) and cardiovascular disease (CVD) account for more deaths globally than any other condition. In 2018, the WHO reported that NCDs accounted for 71% of global deaths. They also showed that low- and middle-income countries are disproportionately affected by NCDs, accounting for 85% of NCD-related deaths among individuals aged 30-69 y. Among NCDs, CVD is the leading and fourth-leading causes of death, accounting for 19.5 million deaths worldwide in 2018. Furthermore, despite increasing global awareness, the prevalence of these conditions continues to increase at alarming rates. Deaths from CVD are expected to reach 23.6 million annually by 2030 from 17.6 million deaths in 2016. The underlying aetiology of these conditions is complex, as they can be influenced by several environmental, genetic, and behavioural factors. However, diet and nutrition play a particularly important role in these conditions, especially in the context of the double burden of malnutrition facing many low- and middle-income countries.
Eligibility criteria
Qualifiers
General healthy subjects during enrolment
Age 18 and above
Willing to comply with interventional plan and comes to do follow up
Willing to gives consent
Disqualifiers
Use nonsteroidal anti-inflammatory drugs (NSAIDs) more than once a week during enrolment
Use of anticoagulants or corticosteroids
Use of individual supplements of vitamin A, E, or beta carotene more than once a week during enrolment
Renal failure or dialysis, cirrhosis, other serious conditions that precluded participation
Trial design
Treatments tested in this trial
- Perfect Heartio Drink
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and collaborators
The Perfect Series Sdn Bhd
Lead sponsor
UCSI University
Collaborator